MarketCap
Facebook
X
Telegram
Onconova Therapeutics EV - Enterprise Value | ONTX
Annual EV - Enterprise Value Onconova Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.43 M | 36.8 M | -7.71 M | -12.2 M | -2.79 M | 111 M | -5.45 M | 5.63 M | 24.7 M | 7.86 M | 7.13 M | 63.5 M | 125 M | -40.7 M | 140 M | -7.34 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 140 M | -40.7 M | 28.3 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Collegium Pharmaceutical
COLL
|
2.52 B | $ 24.19 | -3.86 % | $ 766 M |  USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
119 M | $ 3.07 | 7.34 % | $ 40.9 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
434 M | $ 1.26 | -0.79 % | $ 57.6 M |  Israel |
 |
AnaptysBio
ANAB
|
1.46 B | $ 46.46 | 1.92 % | $ 1.35 B | USA |
 |
Assembly Biosciences
ASMB
|
301 M | $ 20.43 | 2.17 % | $ 229 M | USA |
 |
Adagene
ADAG
|
176 M | $ 1.99 | -1.73 % | $ 117 M |  China |
 |
Benitec Biopharma
BNTC
|
388 M | $ 9.51 | 10.07 % | $ 443 M | USA |
 |
Denali Therapeutics
DNLI
|
2.34 B | $ 20.09 | 1.88 % | $ 3.47 B | USA |
 |
Amarin Corporation plc
AMRN
|
5.88 B | $ 11.55 | -0.2 % | $ 4.79 B |  Irlanda |
 |
Editas Medicine
EDIT
|
218 M | $ 2.57 | 0.59 % | $ 228 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
1.65 B | $ 29.4 | 4.0 % | $ 1.7 B | USA |
 |
Cue Biopharma
CUE
|
18 M | $ 18.93 | 5.11 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
91.1 M | $ 1.54 | 15.79 % | $ 88.2 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
134 M | $ 1.73 | 4.22 % | $ 98.4 M | USA |
 |
Pliant Therapeutics
PLRX
|
80.2 M | $ 0.81 | -0.12 % | $ 49.7 M | USA |
 |
Abeona Therapeutics
ABEO
|
234 M | $ 4.18 | 6.78 % | $ 221 M | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
-115 M | $ 4.36 | 8.19 % | $ 706 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
3.81 B | $ 21.22 | -0.09 % | $ 3.57 B | USA |
 |
PainReform Ltd.
PRFX
|
1.3 M | $ 0.85 | 11.62 % | $ 551 K | Israel |
 |
Jazz Pharmaceuticals plc
JAZZ
|
9.15 B | $ 235.01 | 3.38 % | $ 14.3 B | Irlanda |
 |
Atossa Therapeutics
ATOS
|
13.6 M | $ 2.14 | 5.94 % | $ 18.4 M | USA |
 |
Liquidia Corporation
LQDA
|
3.04 B | $ 44.53 | 0.08 % | $ 3.83 B | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
-29.8 M | - | -7.31 % | $ 49 M | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
880 M | - | - | $ 1.77 B | USA |
 |
ADC Therapeutics SA
ADCT
|
386 M | $ 1.59 | -2.16 % | $ 202 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
1.26 B | $ 33.1 | 1.96 % | $ 1.9 B | USA |
 |
Ardelyx
ARDX
|
1.89 B | $ 2.88 | -3.85 % | $ 694 M | USA |
 |
Akebia Therapeutics
AKBA
|
493 M | $ 0.39 | -7.57 % | $ 100 M | USA |
 |
Alector
ALEC
|
444 M | $ 2.3 | 9.81 % | $ 237 M | USA |
 |
ALX Oncology Holdings
ALXO
|
131 M | $ 1.16 | 0.43 % | $ 62.2 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
4.03 B | $ 20.13 | 3.5 % | $ 6.31 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
847 M | $ 3.65 | -0.54 % | $ 699 M |  Canada |
 |
Agenus
AGEN
|
94.8 M | $ 7.13 | 10.71 % | $ 212 M | USA |
 |
AbCellera Biologics
ABCL
|
1.22 B | $ 11.89 | 6.83 % | $ 3.55 B | Canada |
 |
Artelo Biosciences
ARTL
|
3.73 M | $ 1.98 | -6.62 % | $ 375 K | USA |
|
Immatics N.V.
IMTX
|
389 M | $ 6.36 | 2.91 % | $ 778 M |  Germany |
 |
Aptevo Therapeutics
APVO
|
-10.4 M | $ 1.24 | -2.36 % | $ 391 K | USA |
 |
Aligos Therapeutics
ALGS
|
82.6 M | $ 4.14 | -8.2 % | $ 40.9 M | USA |
 |
Aclaris Therapeutics
ACRS
|
422 M | $ 3.9 | 8.03 % | $ 478 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
2.7 B | $ 27.98 | 4.29 % | $ 4.25 B | USA |
 |
Cellectar Biosciences
CLRB
|
-651 K | $ 1.24 | 7.83 % | $ 3.23 M | USA |
|
Larimar Therapeutics
LRMR
|
354 M | $ 2.4 | 3.23 % | $ 199 M | USA |
 |
Biofrontera AG
BFRA
|
744 M | - | -8.24 % | $ 105 M | Germany |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
168 B | - | -6.97 % | $ 657 M | USA |
 |
Capricor Therapeutics
CAPR
|
1.21 B | $ 8.97 | 4.3 % | $ 417 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.92 B | $ 28.5 | 3.04 % | $ 1.33 B | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
15.4 B | - | 1.68 % | $ 4.65 B | China |
 |
Aquestive Therapeutics
AQST
|
540 M | $ 3.6 | -1.64 % | $ 385 M | USA |
 |
Jaguar Health
JAGX
|
57 M | $ 0.4 | -2.16 % | $ 933 K | USA |
 |
Arvinas
ARVN
|
1.01 B | $ 6.41 | -2.14 % | $ 454 M | USA |